(Q33863512)

29 July 2017

1 reference

title

Cyanobacteria: an emerging source for drug discovery (English)

1 reference

29 July 2017

1 reference

1 reference

Rahul Kunwar Singh

1

1 reference

29 July 2017

Shree Prakash Tiwari

series ordinal

2

1 reference

29 July 2017

Ashwani K Rai

series ordinal

3

1 reference

29 July 2017

Tribhuban M Mohapatra

series ordinal

4

1 reference

29 July 2017

publication date

6 April 2011

1 reference

The Journal of Antibiotics

29 July 2017

published in

1 reference

29 July 2017

volume

64

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

401-412

1 reference

https://scigraph.springernature.com/pub.10.1038/ja.2011.21

29 July 2017

exact match

0 references

cites work

New aspects of natural products in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Natural products as sources of new drugs over the period 1981-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Estimating the cost of new drug development: is it really 802 million dollars?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Cell differentiation and colony alteration of an edible terrestrial cyanobacterium Nostoc flagelliforme, in liquid suspension cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Early Archean (3.3-billion to 3.5-billion-year-old) microfossils from Warrawoona Group, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Bioactive compounds from cyanobacteria and microalgae: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Prediction of biological activity profiles of cyanobacterial secondary metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Distribution and diversity of natural product genes in marine and freshwater cyanobacterial cultures and genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Nonribosomal peptides: from genes to products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

A functional genomics approach to the mode of action of apratoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

The recombinant beta subunit of C-phycocyanin inhibits cell proliferation and induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Isolation of an antiviral polysaccharide, nostoflan, from a terrestrial cyanobacterium, Nostoc flagelliforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Potent anti-HIV activity of scytovirin domain 1 peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Carbamidocyclophanes A-E, chlorinated paracyclophanes with cytotoxic and antibiotic activity from the Vietnamese cyanobacterium Nostoc sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Antimicrobial ambiguines from the cyanobacterium Fischerella sp. collected in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Two new antibacterial norabietane diterpenoids from cyanobacteria, Microcoleous lacustris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Activity of blue green microalgae extracts against in vitro generated Staphylococcus aureus with reduced susceptibility to vancomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Antileishmanial structure-activity relationships of synthetic phospholipids: in vitro and in vivo activities of selected derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Ambigol C and 2,4-dichlorobenzoic acid, natural products produced by the terrestrial cyanobacterium Fischerella ambigua

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Potent and selective antiplasmodial activity of the cyanobacterial alkaloid nostocarboline and its dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Isolation of aerucyclamides C and D and structure revision of microcyclamide 7806A: heterocyclic ribosomal peptides from Microcystis aeruginosa PCC 7806 and their antiparasite evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Cyanopeptolin 963A, a chymotrypsin inhibitor of Microcystis PCC 7806.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Cyanopeptolin 954, a chlorine-containing chymotrypsin inhibitor of Microcystis aeruginosa NIVA Cya 43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Planktocyclin, a cyclooctapeptide protease inhibitor produced by the freshwater cyanobacterium Planktothrix rubescens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Kempopeptins A and B, serine protease inhibitors with different selectivity profiles from a marine cyanobacterium, Lyngbya sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Spirulina platensis exposure enhances macrophage phagocytic function in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Nutritional and therapeutic potential of Spirulina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

A randomized double-blind, placebo-controlled study to establish the effects of spirulina in elderly Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Effects of cyanobacteria bloom extract on some parameters of immune function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Expression modulation of multiple cytokines in vivo by cyanobacteria blooms extract from Taihu Lake, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Cyanobacteria from benthic mats of Antarctic lakes as a source of new bioactivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

Secondary Metabolites from Cyanobacteria: Complex Structures and Powerful Bioactivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

Structure of Curacin A, a Novel Antimitotic, Antiproliferative and Brine Shrimp Toxic Natural Product from the Marine Cyanobacterium Lyngbya majuscula

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

Antiviral properties of fucoidan fractions from Leathesia difformis.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

Cyclic Depsipeptides, Ichthyopeptins A and B, fromMicrocystisichthyoblabe

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

The inhibition of the reverse transcriptase of HIV-1 by the natural sulfoglycolipids from cyanobacteria: contribution of different moieties to their high potency

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

Cyanobacteria--a potential source of new biologically active substances

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

A novel extracellular diterpenoid with antibacterial activity from the cyanobacterium Nostoc commune

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

Enhancement of antibody production in mice by dietary Spirulina platensis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

Biochemical and pharmacological investigations of selected cyanobacteria

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.21

7 January 2021

Identifiers

DOI

10.1038/JA.2011.21

1 reference

Dimensions Publication ID

29 July 2017

1002374760

0 references

1 reference